The diagnostic performance of the spectral biomarkers was assessed using multivariate logistic regression and ROC analysis, achieving an AUC of 0.91 (95% CI 0.81–1.0). Notably, these spectral biomarkers outperformed traditional circulating HCC markers, including AFP and PIVKA-II. Here, AFP is linked to hepatocellular carcinoma.